CSRM617 is a Transcription Factor ONECUT2 Inhibitor for Prostate Cancer
The transcription factor ONECUT2 (OC2) is a master regulator of androgen receptor networks in mCRPC (metastatic castration-resistant prostate cancer ). OC2 acts as a survival factor in mCRPC models. OC2…